Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 01, 2018
Lannett has approved a plan to sell Cody Laboratories, a subsidiary that produces active pharmaceutical ingredients (API) used in prescription pain medications.
read more
Friday, November 08, 2019
Cognate BioServices and Cobra Biologics have entered into a definitive agreement in which Cognate will acquire all of the outstanding share capital of Cobra.
read more
Cognate BioServices, a contract development and manufacturing organization in the global cellular therapies industry, has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW ...
read more
Wednesday, January 20, 2021
Cobra Biologics, the gene therapy division of the Cognate BioServices’ group, has announced a multi-phase augmentation of its plasmid DNA services as a continuation of its Gene Therapy services’ expansion project for viral vectors and plasmid DNA.
read more
Wednesday, November 04, 2020
Cognita Labs announced the FDA has issued clearance for PulmoScan, a home-usable lung assessment device that measures airway resistance and elastance.
read more
Wednesday, January 20, 2016
Cognition Life Science, Inc. has selected Smart Science Laboratories Inc. as an FDA/GMP manufacturer for the production of its product for sleep disorders.
read more
Wednesday, February 09, 2022
Cognizant will provide Medable with strategic advisory services, technology deployment and best-in-class global support to help Medable customers reduce clinical trial timelines, improve the patient experience, and bring effective therapies to market...
read more
Cold Chain Technologies (CCT), a leading global
designer, manufacturer and distributor of temperature controlled packaging solutions, is
pleased to announce its expansion into the Latin American (LatAm) temperature sensitive
packaging market.
read more
Cold Chain Technologies (CCT) has announced a new partnership with E&I Cooperative Services, a member-owned, non-profit sourcing cooperative for the education sector.
read more
Friday, September 20, 2013
Coldstream Laboratories, Inc., a provider of parenteral manufacturing and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development. In this position, Ms. Savoy will be ...
read more
Tuesday, November 19, 2013
Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
read more
Thursday, February 27, 2025
BullFrog AI Holdings, Inc. announced its entry into a collaboration agreement with Eleison Pharmaceuticals Inc. Under the terms of the agreement, BullFrog AI will provide access to its BullFrog Data Networks™ AI solution to enhance clinical trial ...
read more
Tuesday, February 03, 2015
AYOXXA, an international biotech company with headquarters in Cologne, has signed an agreement with the Singapore Eye Research Institute (SERI), one of the leading international eye research institutes. AYOXXA and SERI will work together on ...
read more
SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL announced a new collaboration to develop an inhaled dry powder formulation of SF2523 for the treatment of pulmonary fibrosis, lung cancer and SARS-CoV-2 related illnesses.
read more
The Guardian Research Network and Molecular Health have announced a collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities.
read more